Achieve Life Sciences, Inc. filed 3 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-06-02. Between them they name 3 people, with 1 appointment and 2 departures. Each change below is quoted from the filing and linked to it.
Every change, newest first
Reported
On May 29, 2026, the Board of Directors (the "Board") of Achieve Life Sciences, Inc. (the "Company") appointed Jeff Farrow and Reid Waldman, M.D.
Departing: Thomas King, effective 2026-06-08
On May 7, 2026, Thomas King informed the Board that he has elected to resign from his position as a member and as chairman of the Board, effective as of June 8, 2026.
Departing: Richard Stewart, Chief Executive Officer, effective 2026-04-18
Departure of Chief Executive Officer In connection with the Private Placement, on April 15, 2026, Richard Stewart, the Company's Chief Executive Officer and a director, informed the Company's Board of Directors (the "Board") of his intention to step down from his position as the Company's Chief Executive Officer, President and "principal executive officer," effective as of April 18, 2026 (the "Separation Date").
Appointed: Andrew Goldberg, Chief Executive Officer, effective 2026-04-18
Effective as of April 18, 2026 (the "Appointment Date"), the Company also announced that the Board appointed Andrew Goldberg as the Company's Chief Executive Officer, President and "principal executive officer." Dr. Goldberg was also appointed to the Board, effective as of the Appointment Date.
Find people with the same kind of experience as the Chief Executive Officer at Achieve Life Sciences, Inc., with the record behind each one.
Find candidates like Chief Executive Officer at Achieve Life Sciences, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Achieve Life Sciences, Inc. is in the news or changes leadership.
Get an alert when Achieve Life Sciences, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Achieve Life Sciences, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.